Early research (Phase 1)WithdrawnNCT00492947What this trial is testingDendritic Cell Vaccine for Head and Neck CancerWho this might be right forSquamous Cell Carcinoma of Head and Neck University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00705016What this trial is testingCilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)Who this might be right forSquamous Cell Cancer Merck KGaA, Darmstadt, Germany 184
Large-scale testing (Phase 3)Study completedNCT01156142What this trial is testingDoxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyWho this might be right forHead and Neck CancerMucositisOral Complications of Radiation Therapy+1 more Alliance for Clinical Trials in Oncology 155
Large-scale testing (Phase 3)Study completedNCT02741570What this trial is testingStudy of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Cancer Bristol-Myers Squibb 947
Early research (Phase 1)Looking for participantsNCT05176483What this trial is testingStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+8 more Exelixis 1,394
Testing effectiveness (Phase 2)Study completedNCT00639769What this trial is testingIrinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 41
Early research (Phase 1)UnknownNCT05867303What this trial is testingA RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsWho this might be right forMelanomaUrothelial CarcinomaRenal Cell Carcinoma+3 more RemeGen Co., Ltd. 48
Early research (Phase 1)Not Yet RecruitingNCT07272642What this trial is testingA Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.Who this might be right forImagingColorectal CancerHead and Neck Squamous Cell Carcinoma+2 more Radiopharm Theranostics, Ltd 16
Testing effectiveness (Phase 2)Study completedNCT04815720What this trial is testingPepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) Vaccinex Inc. 49
Testing effectiveness (Phase 2)Study completedNCT02762513What this trial is testingExpansion Trial for Axitinib In Head And Neck CancerWho this might be right forSquamous Cell Carcinoma of the Head and Neck University of Michigan Rogel Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00004070What this trial is testingGene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT02001623What this trial is testingTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsWho this might be right forOvary CancerCervix CancerEndometrium Cancer+5 more Seagen Inc. 195
Large-scale testing (Phase 3)Active Not RecruitingNCT06525220What this trial is testingEvaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)Who this might be right forHead and Neck Squamous Cell Carcinoma Merus B.V. 699
Large-scale testing (Phase 3)Looking for participantsNCT06022861What this trial is testingCompare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Shandong Boan Biotechnology Co., Ltd 510
Testing effectiveness (Phase 2)Study completedNCT00095927What this trial is testingRandomized Amifostine For SCCHNWho this might be right forChemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more Dana-Farber Cancer Institute 58
Testing effectiveness (Phase 2)Study completedNCT03818061What this trial is testingAtezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Neoplasms Centre Leon Berard 33
Early research (Phase 1)Active Not RecruitingNCT03132922What this trial is testingMAGE-A4ᶜ¹º³²T for Multi-TumorWho this might be right forUrinary Bladder CancerMelanomaHead and Neck Cancer+7 more USWM CT, LLC 71
Early research (Phase 1)Study completedNCT02315066What this trial is testingStudy Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566Who this might be right forNeoplasms Pfizer 174
Large-scale testing (Phase 3)Looking for participantsNCT04747054What this trial is testingStudy on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck CancersWho this might be right forSquamous Cell Carcinoma of Head and Neck UNICANCER 102
Testing effectiveness (Phase 2)Study completedNCT00229723What this trial is testingIRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forNeoplasms, Squamous Cell AstraZeneca 224